+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nano Meets Micro. Revolutionizing Medicine through Microfluidic Devices

  • Book

  • November 2026
  • Elsevier Science and Technology
  • ID: 6251624
Nano Meets Micro: Revolutionizing Medicine through Microfluidic Devices explores the transformative potential of integrating nanotechnology with microfluidics to revolutionize medical diagnostics, treatment, and personalized medicine. The book provides a detailed examination of how these cutting-edge technologies are making healthcare more precise, efficient, and personalized. Sections highlight nanomedicine and microfluidics, highlighting their importance in healthcare and their intersection with advanced healthcare solutions. It covers traditional and emerging fabrication techniques for microfluidic devices, the design and synthesis of nanoparticles, and the integration of nanomedicine into microfluidic systems. Examples and case studies illustrate how these technologies are used in drug delivery, disease diagnosis, and rapid diagnostics.

With a strong focus on future implications, the book discusses emerging trends and potential advances in microfluidics and nanotechnology, including the integration of artificial intelligence and data analytics. It addresses the challenges and future directions in the commercialization of nanomedicine and microfluidic devices, providing a roadmap for translating laboratory innovations into clinical applications.

Table of Contents

Section I: Foundations
1. Introduction to Nanomedicine and Microfluidics

Section II: Fabrication and Design
2. Microfluidic Device Fabrication Techniques
3. Nanoparticles: Design and Synthesis
4. Nanomedicine Applications

Section III: Integration and Applications
5. Integrating Nanomedicine into Microfluidic Systems
6. Microfluidics in Drug Development

Section IV: Diagnostics and Personalized Medicine
7. Advanced Diagnostics with Nanofluidic Devices
8. Personalized Medicine and Specialized Therapeutics

Section V: Challenges and Future Directions
9. Overcoming Challenges
10. Future Directions in Nanomedicine and Microfluidics

Section VI: Conclusion
11. Conclusion and Future Outlook

Authors

Fatemeh Hataminia Tehran University of Medical Sciences, Iran. Dr. Fatemeh Hataminia is a dedicated researcher within the Department of Medical Nanotechnology at Tehran University of Medical Sciences. Her academic journey has been marked by significant contributions to the understanding of nanomaterials and their applications in medicine, particularly through innovative mathematical modeling and experimental studies. Dr. Hataminia has co-authored multiple research articles in respected journals such as Toxicology in Vitro, Nanotoxicology, and Scientific Reports. Her work focuses on the cytotoxicity of nanoparticles, therapeutic effects of phototherapy methods, and advancements in microfluidic technologies for enhanced medical applications. With a strong foundation in both theoretical and practical aspects of nanotechnology and microfluidics, she aims to bridge gaps between these fields to facilitate revolutionary advancements in medical diagnostics and treatments. Hossein Ghanbari Tehran University of Medical Sciences, Iran. Dr. Hossein Ghanbari is an Associate Professor of Nanotechnology & Regenerative Medicine and Dean of the School of Advanced Technologies in Medicine at Tehran University of Medical Sciences (TUMS), Tehran, Iran. He is also the Head of the Department of Medical Nanotechnology and Research Director & Co-Founder of the Research Center for Advanced Technologies in Cardiovascular Medicine at Tehran Heart Center. Dr. Ghanbari completed his PhD in Nanotechnology and Regenerative Medicine at University College London and has held post-doctoral fellowships in skin regeneration and biosecurity. His research focuses on stem cell labeling, tissue engineering, and the development of nanocomposite materials for biomedical applications. He has received numerous awards and serves on several editorial boards.